Veriteq Corp (VTEQ) 0.3000 $VTEQ VeriTeQ Corporation

New Post Public Reply Private Reply Replies (0) Message Board

Oct 11, 2015 at 1:01 AM

Veriteq Corp (VTEQ) 0.3000 $VTEQ

VeriTeQ Corporation Announces Reverse Stock Split
GlobeNewswire - Tue Jul 28, 3:15PM CDT
VeriTeQ Corporation (OTC Markets:VTEQ) ("VeriTeQ" or the "Company"

, a provider of implantable medical device identification and radiation dose measurement technologies, announced today that its Board of Directors and FINRA have approved a reverse split of the Company's common stock at a ratio of 1-for-10,000, commencing at the open of trading on July 29, 2015.

Safety Innovation by Integration -- BrokerBank
PR Newswire - Mon May 18, 12:45PM CDT
VeriTeQ Corporation (OTCBB: VTEQ) provides implantable medical device identification and radiation dose measurement technologies to the healthcare industry in the United States. It develops devices for measuring the radiation dose delivered to patients during radiation therapy treatment for cancer. The company's Q Inside Safety Technology, is a passive implantable RFID micro-transponder, and a proprietary hand-held reader and corresponding database.

Penny Stocks Buzz for Emrise, First Choice Healthcare Solutions, TapImmune, Veriteq, CANYON COPPER, and MaryJane
PR Newswire - Wed May 13, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Emrise (OTCMKTS:EMRI), First Choice Healthcare Solutions (OTCMKTS:FCHS), TapImmune (OTCMKTS:TPIV), Veriteq (OTCMKTS:VTEQ), CANYON COPPER (OTCMKTS:CNYCF), and MaryJane (OTCMKTS:MJMJ).

VeriTeQ Corporation Comments on This Morning's Today Show Segment Regarding Implantable Radio Frequency Technology
GlobeNewswire - Thu Feb 05, 10:01AM CST
VeriTeQ Corporation ("VeriTeQ" or "Company"

(OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, today commented on this morning's Today Show segment entitled "Company implants microchips in employees." The segment represents that RF (radio frequency) access applications are new or first of a kind. This is not accurate. Specifically, years ago, VeriTeQ's predecessors, VeriChip Corporation/Applied Digital Solutions, received FDA clearance in 2004 to use an implantable RF micro-transponder to access medical records in an emergency or clinical application. One of VeriChip's other applications was building / office access.

VeriTeQ and Logic PD Building Digital Health Solutions for the Internet of Things ("IoT"

Based on Q Inside Safety Technology
GlobeNewswire - Tue Jan 13, 7:56AM CST
VeriTeQ Corporation (OTC Markets:VTEQ) ("VeriTeQ"

a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it is working with Logic PD to build a medical device information system based on VeriTeQ's Q Inside Safety Technology(TM) and Logic PD's experience as an Internet of Things ("IoT"

integrator. Through this hardware and software technology platform, VeriTeQ will bring information about medical devices implanted in the body to outside of the body to provide digital health solutions to patients, physicians, and device manufacturers.

Q Inside Safety Technology Growth Accelerates as Over 5,000 Women Have Now Received Motiva Breast Implants With VeriTeQ's Technology
GlobeNewswire - Tue Dec 09, 8:11AM CST
VeriTeQ Corporation (OTC Markets:VTEQ) ("VeriTeQ"

a provider of implantable medical device identification and radiation dose measurement technologies, announced today that more than 5,000 women have now received Motiva Implant Matrix(R) breast implants, manufactured by Establishment Labs S.A. ("EL"

, with VeriTeQ's Q Inside Safety Technology(TM).

VeriTeQ Corporation and Establishment Labs to Develop a Pressure-Sensing Microtransponder for Use in Tissue Expanders for Breast Reconstruction
GlobeNewswire - Mon Nov 24, 7:57AM CST
VeriTeQ Corporation (OTC Markets:VTEQ) ("VeriTeQ"

a provider of implantable medical device identification and radiation dose measurement technologies, announced today that, in conjunction with its customer Establishment Labs, S.A. ("EL"

, it will initiate development of a pressure-sensing microtransponder to be used in tissue expanders for breast reconstruction and tissue expansion. EL's tissue expanders will incorporate a host of technological features, most importantly giving surgeons the ability to measure internal pressure during the expansion cycles.

VeriTeQ Corporation Announces New Financing With Magna
GlobeNewswire - Wed Nov 05, 8:09AM CST
Magna purchases Hudson Bay Master Fund's Convertible Debt in the Company

VeriTeQ Corporation and Establishment Labs to Host Physician Conference in Europe Based on Demand for Motiva Breast Implants With Q Inside Safety Technology
GlobeNewswire - Wed Oct 15, 8:35AM CDT
VeriTeQ Corporation ("VeriTeQ" or "Company"

(OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that the Company and its breast implant customer, Establishment Labs, S.A., ("EL"

are hosting a physician conference in Salzburg, Austria on October 16, 2014, based on demand for EL's Motiva Implant Matrix(R) breast implants with VeriTeQ's Q Inside Safety Technology(TM).

VeriTeQ Corporation Enters Agreement Providing Exclusive License of Multiple Patents From NC State University
GlobeNewswire - Thu Oct 09, 8:36AM CDT
VeriTeQ Corporation ("VeriTeQ" or "Company"

(OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has entered an agreement providing an exclusive license of multiple patents from North Carolina State University ("NCSU"

. VeriTeQ will license 24 patents, which are the foundation for its FDA cleared Q Inside SmartMarker and OneDose products for radiation dosimetry.

VeriTeQ Receives First Order for 100 Units of Its New Q Inside Readers for Breast Implants
GlobeNewswire - Mon Sep 29, 7:30AM CDT
VeriTeQ Corporation ("VeriTeQ"

(OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has received an order for 100 units of its new Q Inside readers for breast implants. The Q Inside reader identifies VeriTeQ's Q Inside Safety Technology within breast implants and other medical devices.

Photo Release -- VeriTeQ Unveils New Q Inside Safety Technology Readers for Medical Device Identification
GlobeNewswire - Thu Sep 18, 9:34AM CDT
VeriTeQ Corporation ("VeriTeQ"

(OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has unveiled two new readers used to identify VeriTeQ's Q Inside Safety Technology(TM) within implantable medical devices: the Q Inside Reader + and the Q Inside Reader XR +. The new readers are being launched based on demand from the breast implant industry.

VTEQ, Has Remained On Naked Short Lists 13 Consecutive Days
M2 - Wed Sep 17, 9:15AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Has Remained On the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. (OTC:VTEQ). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .

Over 1,000 Women Worldwide Have Now Received Motiva Breast Implants with VeriTeQ's Q Inside Safety Technology
Business Wire - Tue Sep 16, 8:39AM CDT
VeriTeQ Corporation ("VeriTeQ"

(OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that more than 1,000 women worldwide have now received Motiva Implant Matrix(R) breast implants with VeriTeQ's Q Inside Safety Technology(TM). Motiva Implant Matrix(R) breast implants, manufactured by Establishment Labs S.A. ("EL"

, featuring VeriTeQ's Q Inside Safety Technology(TM) can be safely and accurately identified from outside of the body in a physician's office.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Employment Law Suit Hits ABC: Alleged Wage Violations

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Layne's Chicken Fingers Expands with Brownsville Opening

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

EFICYENT Ventures to Connect at Singapore FinTech Fest

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...